Key facts
- A director of Outlook Therapeutics' firm purchased $5 million in common stock.
Insider buying, where company executives or directors purchase shares, is often seen as a positive signal to the market, suggesting a belief in the company's intrinsic value and future growth potential. Such transactions are typically disclosed via SEC filings.
